Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Clinical & Experimental Metastasis|November 29, 2011
Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic diseaseMichael M Vickers, Jair Bar, Ivan Gorn-Hondermann, et al.
The British Journal of Radiology|September 26, 2023
Effects of EGFR driver mutations on pathologic regression in resectable locally advanced non-small cell lung cancer treated with neoadjuvant chemoradiation and completion surgerySarit Appel, Jair Bar, Akram Saad, et al.
Lung Cancer (Amsterdam, Netherlands)|December 20, 2017
Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life dataElizabeth Dudnik, Mor Moskovitz, Sameh Daher, et al.
Lung Cancer (Amsterdam, Netherlands)|August 9, 2021
Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancerByoung Chul Cho, Kiyotaka Yoh, Ruth Perets, et al.
Nature Cancer|March 4, 2022
The interaction of CD4<sup>+</sup> helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade responseMerav Cohen, Amir Giladi, Oren Barboy, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2025
Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumabFrancesco Cortiula, Talia Shentzer Kutiel, Melinda L Hsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2018
BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point InhibitorsElizabeth Dudnik, Nir Peled, Hovav Nechushtan, et al.
Translational Oncology|November 13, 2020
Long term follow-up of EGFR mutated NSCLC casesGad Rennert, Maya Gottfried, Hedy S Rennert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2021
Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III StudySuresh S Ramalingam, Silvia Novello, Salih Zeki Guclu, et al.
Clinical Lung Cancer|May 8, 2019
Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life CohortElizabeth Dudnik, Jair Bar, Nir Peled, et al.
Pageof 12